AI assistant
Dynatrace, Inc. — Director's Dealing 2019
Aug 3, 2019
30410_dirs_2019-08-02_c87bcb88-613a-4251-9128-a067b224ec5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dynatrace, Inc. (DT)
CIK: 0001773383
Period of Report: 2019-07-31
Reporting Person: Van Siclen John (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-31 | Common Stock | A | 83000 | $0.00 | Acquired | 2703827 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-31 | Stock Option (Right to Buy) | $16.00 | A | 553000 | Acquired | 2029-07-31 | Common Stock (553000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 502025 | Indirect |
| Common Stock | 903645 | Indirect |
| Common Stock | 7531 | Indirect |
Footnotes
F1: Consists of Restricted Stock Units ("RSUs") issued under the Dynatrace, Inc. 2019 Equity Incentive Plan. Each RSU represents the right to receive one share of Common Stock.
F2: Shares held by the John W. Van Siclen 2019 Irrevocable Trust, for which the Concord Trust Company serves as trustee. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3: Shares held by the Nancy R. Van Siclen 2019 Irrevocable Trust, for which the Concord Trust Company serves as trustee. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4: Stock options granted on July 31, 2019, 25% of which shall vest and become exercisable on August 15, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.